Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Evidence-Based Complementary and Alternative Medicine : Ecam|December 27, 2013
The efficacy and safety of traditional chinese medicine (jiang zhi granule) for nonalcoholic Fatty liver: a multicenter, randomized, placebo-controlled studyJielu Pan, Miao Wang, Haiyan Song, et al.BMC Complementary and Alternative Medicine|November 30, 2017
Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt/β-catenin signaling in colorectal cancer cellsJielu Pan, Yangxian Xu, Haiyan Song, et al.Annals of Palliative Medicine|August 6, 2021
Fibrates for the treatment of pruritus in primary biliary cholangitis: a systematic review and meta-analysisNan Shen, Jielu Pan, Hongyu Miao, et al.Journal of Biomedical Nanotechnology|January 21, 2022
Development of Saikosaponin D Liposome Nanocarrier with Increased Hepatoprotective Effect Against Alcoholic Hepatitis MiceXiao Yu, Jielu Pan, Nan Shen, et al.Pharmaceutical Biology|December 17, 2021
Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitisXiao Yu, Haiyan Zhang, Jielu Pan, et al.International Journal of Molecular Sciences|December 31, 2014
Increased ARPP-19 expression is associated with hepatocellular carcinomaHaiyan Song, Jielu Pan, Yang Liu, et al.Annals of Translational Medicine|March 16, 2023
Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver diseaseNan Shen, Ling Tang, Yufan Qian, et al.Journal of Translational Medicine|May 6, 2024
Chronic atrophic gastritis and risk of incident upper gastrointestinal cancers: a systematic review and meta-analysisJunqiu Li, Jielu Pan, Dinghong Xiao, et al.BMJ Open|September 14, 2024
Investigating the efficacy of acupuncture in treating patients with metabolic-associated fatty liver disease: a protocol for a randomised controlled clinical trialLihong Fu, Lingying Huang, Yueqiu Gao, et al.BMC Cancer|August 8, 2025
Decoding the epigenetic-immune nexus in hepatocellular carcinoma: a Mendelian randomization study reveals BTN3A2, S100A12 and TRIM27 as white blood cell regulatorsYang Qiu, Haiyan Zhang, Xiao Yu, et al.Pageof 1